Navigation Links
Hormones in Biological Technology

New Analysis Finds Bioidentical Hormones Safer Than Standard Hormone Replacement Therapy

... Comprehensive review demonstrates bioidentical hormones are superior to synthetic HRT with greater ... practicing clinicians, showed that bioidentical hormones are associated with reduced health risks and are ... state that there is no evidence that bioidentical hormones are safer than synthetic HRT. A thorough review ...

Bio-Identical Hormone Menopause Doctor Responds to Outrageous FDA News

... and estriol -- progesterone, and other compounded hormones was very surprising to me and other medical ... Board certified in Ob/Gyn and founded what is now hormones by Hart in 1997. She is also the medical director of hormones by Hart. The FDA stated on January 9, 2008 that ...

The Need for Safe and Affordable Biopharmaceuticals Drives the Development of the European Biosimilars Market, Says Frost & Sullivan

... insulin and analogs, granulocyte colony-stimulating factors, human growth hormones and interferons, which have all lost patent protection, had a collective ... Vaccines Market, European Biosimilars Market, European Human Growth hormones Market, European Therapeutic Monoclonal Antibody Market, European Drug ...

First Taxane-Based Non-Anthracycline Containing Chemotherapy in Combination With Herceptin (TCH) for HER2 Positive Early Breast Cancer Patients Obtains Approval From the FDA

... was present regardless of a patient's age, the tumor responsiveness to hormones (hormone receptor status), or whether or not the cancer had spread to ... was present regardless of a patient's age, the tumor responsiveness to hormones (hormone receptor status), or whether or not the cancer had spread to ...

JCI table of contents: April 22, 2008

... of sex hormone production regulated itself? The production of the sex hormones testosterone, progesterone, and estrogen is controlled by two other ... in the levels of either LH or FSH affect the production of sex hormones and can cause either premature or delayed puberty as well as infertility. ...

Bio-Identical Hormone Menopause Doctor Responds to Recent FDA News About Estriol

... Mayo Clinic trained and Board certified in Ob/Gyn and founded what is now hormones by Hart in 1997. She is also the medical director of Hormones by Hart. ... from its use. I want my patients to know that all of their prescription hormones are still going to be available," promises Cheryle R. Hart, M.D. If you ...

Amylin Pharmaceuticals Announces Positive Results from Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment for Obesity

... of neurohormones in the physiological regulation of appetite and energy balance, as well as the importance of studying the interaction among these hormones (within the brain) to uncover their full therapeutic potential. Amylin scientists discovered that combination treatment with neurohormones, such as ...

PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin

... in St. Louis, which has exclusively licensed rights for the use of CTP with all therapeutic proteins to PROLOR, with the exception of four endocrine hormones licensed to Schering-Plough. PROLOR plans to initiate human clinical trials with hGH-CTP, its longer-acting version of human growth hormone, later ...

Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEO

... Hollis-Eden Pharmaceuticals, Inc. is developing a new series of small molecule compounds that are metabolites or synthetic analogs of endogenous hormones derived by the adrenal glands from the body's most abundant circulating adrenal steroid. The Company's clinical drug development candidates include ...

Histogen Aesthetics Launches ReGenica Rejuvenation System

... does not contain genetically-engineered growth factors (recombinant proteins) does not contain fetal bovine or other animal serum, so no animal hormones are present "Our patients undergoing cosmetics procedures are very interested in minimizing their downtime as well as minimizing their risk, ...

INVO Bioscience Completes Reverse Merger

... The INVOcell and INVO Procedure combine a natural or mild stimulation infertility treatment cycle, using lower amounts of injectable fertility hormones than used in traditional IVF(in vitro fertilization), with intra-vaginal incubation (IVC) of sperm and eggs. Following standard egg retrieval, the ...

Calvert Research and CureDM Sign Collaborative Agreement

... 1 and 2 diabetes patients. HIP has a novel mechanism of action that works by stimulating the generation of new islet structures which secrete key hormones like insulin to normalize glucose levels in the blood. "We appreciate that Calvert has recognized the potential value of HIP to the extent that ...

Global Biopharmaceutical Leader in Peptide Research Expands Commitment in San Diego/U.S. With New R&D Facility and Ready-To-Market Prostate Cancer Treatment Degarelix

... Pharmaceuticals as a center for peptide research. Located in San Diego the Institute's peptide technology focuses on naturally-occurring peptides, hormones and receptors which control the body's major biological functions and physio-pathological processes. The most advanced peptide discovered by Ferring ...

You Want To Have a Baby...But Not Eight

... woman's ovaries." If too many follicles have developed, doctors can skip the cycle and try again with a lower dose of the follicle-stimulating hormones or harvest and freeze the eggs for later in vitro fertilization, an innovative process used at GRS, he explained. In vitro fertilization allows the ...

Novel Diabetes Drug Discovery Has Potential to Reverse Disease

... as a therapeutic approach. Pancreatic islets contain four primary cell types and are responsible for producing insulin, amylin, glucagon and other hormones critical to maintaining normal glucose regulation. Current diabetes therapies, including insulin, help to control the disease but do not restore new ...

Modigene Awarded Second-Year Grant by Israeli Government to Support Development of Its Longer-Acting Human Growth Hormone

... It has an exclusive license from Washington University to the CTP technology for use with all therapeutic proteins except for the four endocrine hormones licensed to Schering-Plough. ABOUT MODIGENE Modigene Inc. is a biopharmaceutical company applying its patented CTP technology to develop ...

ABAXIS Announces Worldwide Animal Health Licensing Agreement for Rapid Test Technology

... portfolio and enter on a large scale the professional veterinary rapid diagnostic market. This includes point of care tests for infectious diseases, hormones and therapeutic drugs. The total market for these types of tests in the animal health and laboratory animal research is estimated to be over ...

Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results

... Testosterone Levels Throughout Treatment -- Results From Two-Year Study Confirming SUPPRELIN LA Implant Maintains Profound Suppression of hormones in Children with Premature Onset Puberty -- Completion of Enrollment in Phase III Trial of PRO 2000 -- Phase III Clinical Trial of ...

Metabolex Announces Positive Results From Phase 1a Clinical Trial of MBX-2982

... studies conducted by Metabolex and others show that GPR119 agonists can stimulate glucose-dependent insulin secretion and release of incretin hormones such as GLP-1, and thus may preserve beta cell health. This novel dual mechanism may provide a unique therapeutic benefit in the treatment of type ...

New England Peptide Forms Scientific Advisory Board

... Inc. (San Diego), where he leads the peptide chemistry core team with a focus in discovery, synthesis and development of novel peptide hormones for diabetes, obesity and neuropsychiatric therapies. With more than 20 years of experience in drug discovery, and inflammation and metabolic ...

FDA Continues Review of Takeda's New Drug Application for Alogliptin (SYR-322), a DPP-4 Agent for Type 2 Diabetes

... About DPP-4 Inhibitors DPP-4 inhibitors inhibit the enzyme dipeptidyl peptidase-4 (DPP-4), which selectively metabolizes the insulin-increasing hormones glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP). By maintaining the blood levels of GLP-1 and GIP, DPP-4 ...

Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today

... Factor Binding Protein -5 with a single product to enhance treatment sensitivity and delay tumor progression. IGFBP-2 and IGFBP-5 are both hormones that make an alternate hormone, IGF-1, available to the tumor that facilitates continued tumor growth. Employing OGX-225 as a single ...

Addrenex Pharmaceuticals Licenses New Compound to Sciele Pharma for the Treatment of Hypertension and Other Potential Indications

... target specific subtypes of the alpha-2 receptor. Alpha-2 receptors are present throughout the brain and body. They bind with adrenergic hormones and neurotransmitters such as adrenalin and noradrenalin to control a wide range of physiological functions. Malfunctions in the alpha-2 receptor ...

'Breakthroughs Ahead,' Endocrine Society Tells Security Analysts

... stress plays in anxiety, depression and hypertension, and new ways to treat those conditions. -- Breakthrough research results on new hormones to treat menopausal symptoms without increased breast cancer risk. Dr. Keith L. Parker, Chair of the Annual Meeting Steering Committee for ENDO ...

Sonus Pharmaceuticals and OncoGenex Technologies to Merge

... Factor Binding Protein -5 with a single product to enhance treatment sensitivity and delay tumor progression. IGFBP-2 and IGFBP-5 are both hormones that make an alternate hormone, IGF-1, available to the tumor that facilitates continued tumor growth. Employing OGX-225 as a single ...

Two Year Study Confirms SUPPRELIN(R) LA Implant Maintains Profound Suppression of Hormones in Children With Premature Onset Puberty

... provide a continuous release over 12 months of approximately 65 mcg/day of the gonadotropin releasing hormone agonist (GnRHa) histrelin to reduce sex hormones and delay early puberty. SUPPRELIN LA is contraindicated in patients with hypersensitivity to GnRH or GnRH analogs. About Central Precocious ...

AspenBio Pharma to Present at the Roth Capital Partners 20th Annual Growth Stock Conference

... potential. The company was originally formed to produce purified proteins for diagnostic applications and has become a leading supplier of human hormones to many of the nation's largest medical diagnostic companies and research institutions. The company has successfully leveraged this foundational ...

European Commission gives grant to investigate transatlantic oversight of nanotech

... States ( www.lse.ac.uk/nanoregulation ). In recent years, several transatlantic conflicts have erupted over how to regulate chemicals, beef hormones and genetically modified food. These disputes have shown the need for better international coordination of risk assessment and management. But how ...

EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study

... and the presence of a carcinoid tumor increases the probability of other cancers in the digestive system. Carcinoid tumors often release certain hormones into the bloodstream that cause symptoms such as facial flushing, wheezing, diarrhea, and a fast heartbeat. These symptoms are grouped together and ...

Georgia Reproductive Specialists is First in Southeast to Offer Pioneering Test of Women's Biological Clock

... innovative blood test that provides an assessment of a woman's egg supply by combining multiple factors, including the measurement of ovary-related hormones AMH, Inhibin B, and FSH. The window of opportunity for a woman to have children by natural conception is dependent upon an adequate supply of eggs, ...

AspenBio Pharma Closes $18.2 Million Private Placement of Common Stock

... potential. The company was originally formed to produce purified proteins for diagnostic applications and has become a leading supplier of human hormones to many of the nation's largest medical diagnostic companies and research institutions. The company has successfully leveraged this foundational ...

AspenBio Pharma Announces $18 Million Private Placement of Common Stock

... potential. The company was originally formed to produce purified proteins for diagnostic applications and has become a leading supplier of human hormones to many of the nation's largest medical diagnostic companies and research institutions. The company has successfully leveraged this foundational ...

AspenBio Pharma Pursues FDA 510(k) Application Pathway for Appendicitis Blood Test

... potential. The company was originally formed to produce purified proteins for diagnostic applications and has become a leading supplier of human hormones to many of the nation's largest medical diagnostic companies and research institutions. The company has successfully leveraged this foundational ...

MannKind Announces Positive Results from a Phase 1a Study of a GLP-1 Formulation

... GLP, MKC253 may have therapeutic potential in obesity. At present, this indication for GLP-1 is currently limited by the need to administer peptide hormones by injection. The results of this trial, although preliminary, indicate once again that utilizing the Technosphere platform to deliver a ...

Salugen Expands U.S. Distribution and Announces a Partnership with DNA Dimensions to Bring DNA Customized Nutritional Solutions to Metro Detroit Area

... five important genes effecting weight, GenoTrim ingredients and dosages are genetically-guided to address the underlying genetic factors involved in hormones and metabolism that Harvard Medical Experts suggest influence 70% to 80% of overweight cases. By addressing genetic factors that make individuals ...

AspenBio Pharma to Present at the Oppenheimer Best Ideas 1x1 Conference

... potential. The company was originally formed to produce purified proteins for diagnostic applications and has become a leading supplier of human hormones to many of the nation's largest medical diagnostic companies and research institutions. The company has successfully leveraged this foundational ...

AspenBio Pharma to Present the Edgewater Research Investor Conference

... potential. The company was originally formed to produce purified proteins for diagnostic applications and has become a leading supplier of human hormones to many of the nation's largest medical diagnostic companies and research institutions. The company has successfully leveraged this foundational ...

Bone-growing nanomaterial could improve orthopaedic implants

... that can sense bone growth then send that information to an external device. Doctors could monitor the output and determine whether to inject growth hormones or otherwise intervene to avoid additional surgery. Right now, implant patients must get an X-ray or undergo a bone scan to monitor bone growth. ...

The International Diabetes Federation (IDF) Recommends Tighter Control of Blood Glucose Levels After Meals in People With Diabetes

... insulin secretion, decreased sensitivity to insulin action, inability to suppress glucose output from the liver and deficiencies in other hormones related to digestion. The new IDF Guideline recommends that people with diabetes try to keep postmeal blood glucose levels to less than 7.8 mmol/l ...

Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases

... to preserve pancreatic function, thereby enhancing insulin secretion. About glucocorticoid receptor (GCCR), target of ISIS 377131 Glucocorticoid hormones have a variety of effects throughout the body, including promoting liver glucose production and fat storage. Although inhibition of GCCR has long ...
Other Contents
(Date:7/29/2014)... In this fascinating journey to the edge of science, ... new book The Beginning and the End: Does our ... it cyclic? Are we alone in the universe? What ... cosmic evolution? Grounded in science and committed to philosophical ... rise of intelligent life is not an accident, but ...
(Date:7/29/2014)... 29, 2014  When it comes to technology, healthcare is usually ... the last. However, when it comes to wearables, healthcare is trying ... for the Internet of Things and its wearable cousins is less ... the healthcare industry, whether it,s in the hospital for a major ... With that in mind, InformationWeek editor Rodney Brown ...
(Date:7/29/2014)... genetics company, has received from the National Institutes ... a two-year project to support the further development ... genetic discovery. , Specifically, the grant supports ... web-based surveys to improve the company,s ability to ... survey tools to support the collection of a ...
Breaking Biology News(10 mins):Book: 'The Beginning and the End' 223andMe scientists receive approximately $1.4 million in funding from National Institutes of Health 223andMe scientists receive approximately $1.4 million in funding from National Institutes of Health 3
(Date:7/29/2014)... 29, 2014 The One Minute Herpes Cure ... Freeman, an herbal medicine specialist. Alison Freeman wanted to show ... , People interested in finding out more about this ... download it, as it is currently available in online format. ... natural remedies and herbal medicine tips that can help them ...
(Date:7/29/2014)... July 29, 2014 The Natural Multiple ... the inside story to Gary M. Levin’s cure program. ... cure method for this serious disorder. Levin says that ... conditions that can be found in patients. , ... surgeon. For many years, Levin has worked with patients ...
(Date:7/29/2014)... DailyGossip.org reveals in its Stop Sciatica in 8 ... of naturally overcoming sciatica, in less than 7 days. ... sufferers that the cure is simple to achieve, when ... method is described as very fast, as it promises ... minutes per day treatment plan. , Read more ...
(Date:7/29/2014)... Parker Waichman LLP, a national law ... by defective drugs and medical devices, reports that a ... Canada who allege that they were never warned about ... low testosterone injection Delatestryl (Court File No. 3704CP/14). The ... Ontario Superior Court of Justice. , “Testosterone lawsuits have ...
(Date:7/29/2014)... Denver, Colorado (PRWEB) July 29, 2014 Daily ... is a powerful and holistic system that will teach users ... been tried by thousands of people, from all over the ... of the symptoms of this disorder in as quickly as ... will be gone faster than imagined. , The Fibroids ...
Breaking Medicine News(10 mins):Health News:One Minute to Herpes Cure Review Reveals Simplest Herpes Treatment 2Health News:Natural Multiple Sclerosis Treatment Review Reveals the Inside Story to Gary M. Levin’s Cure Program 2Health News:Stop Sciatica in 8 Minutes Review Reveals the Way to Cure Sciatica Easily 2Health News:Class Action Lawsuit in Canada Alleges Manufacturer of Delatestryl Testosterone Injection Failed to Warn of Cardiovascular Risks, Parker Waichman LLP Reports 2Health News:Class Action Lawsuit in Canada Alleges Manufacturer of Delatestryl Testosterone Injection Failed to Warn of Cardiovascular Risks, Parker Waichman LLP Reports 3Health News:Amanda Leto’s Fibroids Miracle Review Reveals Clinically Proven Uterine Fibroids Cure System 2
Other TagsOther Tags